The federal government agreed to pay $165 million to Human Genome Sciences Inc. under a contract to supply ABthrax (raxibacumab) to the Strategic National Stockpile. (BioWorld Today)
The federal government agreed to pay $165 million to Human Genome Sciences Inc. under a contract to supply ABthrax (raxibacumab) to the Strategic National Stockpile. (BioWorld Today)
Medarex Inc. is pushing its targeted cancer therapy, ipilimumab, into a registrational trial for untreated metastatic melanoma patients after receiving a special protocol assessment from the FDA. (BioWorld Today)
Medarex Inc. is pushing its targeted cancer therapy, ipilimumab, into a registrational trial for untreated metastatic melanoma patients after receiving a special protocol assessment from the FDA. (BioWorld Today)
The long-anticipated sleep drug indiplon probably will need further studies in the wake of recent approvable and not-approvable letters from the FDA. (BioWorld Today)
